Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy Diageo (DGE) by Cliff D'Arcy in The Motley Fool
- Buy Unilever (ULVR) by Harvey Jones in The Motley Fool
- Buy Legal & General Group (LGEN) by Christopher Ruane in The Motley Fool
- Buy Domino's Pizza Group (DOM) by Lucy Tobin in The Times - Tempus
- Buy Unilever (ULVR) by Charlie Keough in The Motley Fool
- Hold Elementis (ELM) by Tom Winnifrith in ShareProphets
- Sell Lifesafe Holdings (LIFS) by Steve Moore in ShareProphets
- Overweight Spectris (SXS) by Barclays
- Overweight Workspace Group (WKP) by Barclays
- Buy InterContinental Hotels Group (IHG) by Ben McPoland in The Motley Fool
- Avoid Kitwave Group (KITW) by Steve Moore in ShareProphets
- Buy Hiscox Limited (DI) (HSX) by Goldman Sachs
- Buy Rotork (ROR) by Jefferies
- Hold Telecom Plus (TEP) by Tom Winnifrith in ShareProphets
- Strong Buy OptiBiotix Health (OPTI) by Hot Stock Rockets in ShareProphets
- Avoid Surface Transforms (SCE) by Steve Moore in ShareProphets
- Buy InterContinental Hotels Group (IHG) by Bank of America
- Hold GSK (GSK) by DZ Bank
- Neutral Intertek Group (ITRK) by Goldman Sachs
- Neutral InterContinental Hotels Group (IHG) by Goldman Sachs
Angle (AGL) Share Price
Health Care Sector
NOTE: This is based on 33 open tips for Angle (AGL)
| Latest Bid : 16.50p | Latest Ask : 17.50p |
| High Today : 17.45p | Low Today : 15.05p |
| This Years High : 31.40p | This Years Low : 9.25p |
| Volume : 6,681,672 | MKT Cap : £46.15M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Angle (AGL) Overview
ANGLE is a world leading liquid biopsy company with sample to answer solutions. ANGLE's proven patent protected platforms include an epitope-independent circulating tumor cell (CTC) harvesting technology and a downstream analysis system for cost effective, highly multiplexed analysis of nucleic acids and proteins.Angle (AGL) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Berenberg | Premium Only | 2024-04-24 15:01:00 24/04/2024 | 4.41% |
| Watch | Sumayya Mansoor | Premium Only | 2024-01-16 16:35:00 16/01/2024 | – |
| Buy | Royston Wild | Premium Only | 2024-01-11 17:45:00 11/01/2024 | -10.13% |
| Watch | Ben McPoland | Premium Only | 2024-01-08 13:25:00 08/01/2024 | – |
| Buy | Jefferies | Premium Only | 2023-09-14 04:47:00 14/09/2023 | -4.05% |
Angle (AGL) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 16.50p | Latest Ask : 17.50p |
| High Today : 17.45p | Low Today : 15.05p |
| This Years High : 31.40p | This Years Low : 9.25p |
| Volume : 6,681,672 | MKT Cap : £46.15M |
Angle Overview
ANGLE is a world leading liquid biopsy company with sample to answer solutions. ANGLE's proven patent protected platforms include an epitope-independent circulating tumor cell (CTC) harvesting technology and a downstream analysis system for cost effective, highly multiplexed analysis of nucleic acids and proteins.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Angle Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Berenberg | Premium Only | 2024-04-24 15:01:00 24/04/2024 | 4.41% |
| Watch | Sumayya Mansoor | Premium Only | 2024-01-16 16:35:00 16/01/2024 | – |
| Buy | Royston Wild | Premium Only | 2024-01-11 17:45:00 11/01/2024 | -10.13% |
| Watch | Ben McPoland | Premium Only | 2024-01-08 13:25:00 08/01/2024 | – |
| Buy | Jefferies | Premium Only | 2023-09-14 04:47:00 14/09/2023 | -4.05% |